Broncho-Munal 7mg 30 capsules — Made in Slovenia — Free Delivery

Product description

Broncho-munal contains lyophilized lysate of bacteria most commonly associated with respiratory tract infections, including Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Streptococcus viridans, Streptococcus pyogenes, Moraxella cat.

The preparation stimulates the body's natural defenses against respiratory tract infections, reducing the frequency, duration and severity of respiratory tract infections, and also reduces the need for antibiotics.

The preparation activates the cellular and humoral immune response of the mucous membrane of the respiratory tract and other immunocompetent structures of the body. It also stimulates the body's non-specific immune response. In preclinical and clinical studies, the following effects of the preparation on the body's defense mechanisms have been demonstrated:

• stimulates alveolar macrophages, which secrete cytokines, protect the body from infections;
• increases the number of CD4 T-lymphocytes population;
• activates peripheral mononuclear cells that perform a protective function;
• increases the concentration of secretory IgA on the mucous membranes of the respiratory tract and digestive tract
• stimulates the formation of protective adhesive molecules;
• reduces the content of IgE in blood plasma, which can suppress the development of hypersensitivity reactions.

Indications

Use to prevent recurrence of respiratory tract infections.

Contraindications

Hypersensitivity to the active substance or any excipient included in the preparation.

Structure

Active ingredients: 1 capsule contains 7 mg of lyophilized lysate of the bacteria Haemophilus influenzae, Streptococcus (Diplococcus) pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Moraxella (Branhamella / Nehalrisseria);

Excipients: propylgalate, sodium glutamate, lures (E 421), magnesium stearate, corn starch;

Shell: indigotine (E 132), titanium dioxide (E 171), gelatin.

Method of administration and dosage

Adults and adolescents over 12 years of age

The cycle of prophylactic treatment of recurrent respiratory tract infections: 1 capsule daily on an empty stomach for 10 consecutive days a month, 3 months in a row.

Treatment can be started in the acute phase of respiratory tract infections in combination with other treatments.

The preparation should be taken in the morning on an empty stomach.

If the patient has forgotten to take the preparation, it should be taken the next morning.

Overdose

There were no clear clinical symptoms of preparation overdose. No cases of overdose have been reported. In case of overdose, consult a doctor.

Adverse Reactions

Reported adverse events classified below according to MedDRA by organ system and frequency: very common (≥ 1/10), common (≥ 1/100 to <1/10), infrequent (≥ 1/1000 to < 1/100), rare (from ≥ 1/10000 to <1/1000), rare (<1/10000), including isolated cases, the frequency is unknown (cannot be estimated from the available data).

From the immune system: infrequently - hypersensitivity reactions (erythematous rash, generalized rash, erythema, edema, eyelid edema, facial edema, peripheral edema, swelling, swelling of the face, itching, generalized itching, shortness of breath).

From the nervous system: often - headache.

From the respiratory system, chest and mediastinal organs: often - cough.

From the gastrointestinal tract: often - diarrhea, abdominal pain infrequently - nausea, vomiting.

On the part of the skin and subcutaneous tissues: often - rash, infrequently - urticaria, the frequency is unknown - angioedema.

General disorders: infrequently - increased fatigue; isolated - fever.

In the case of prolonged gastrointestinal or respiratory distress, treatment should be discontinued. In case of skin reactions, treatment is also interrupted, since these manifestations can be of an allergic nature.

Application features

Application during pregnancy or lactation

The preparation is not used during the first three months of pregnancy.

Patients who intend to become pregnant, or become pregnant, should inform the doctor about this.

The safety of use during pregnancy has not been established, so it is advisable to avoid the use of this preparation during pregnancy.

No studies have been conducted in women who are breastfeeding. Therefore, you should be careful while breastfeeding.

Children

At this dosage, it can be used in children over the age of 12 years.

The ability to influence the reaction rate when driving or driving other mechanisms

Does not affect the ability to drive and use machinery.

Interaction with other medicinal products and other types of interactions

interaction with other preparations is currently unknown.

Storage conditions

Store at a temperature not exceeding 25 ° C in its original packaging to protect against moisture.

Keep out of the reach of children.

The shelf life is 5 years.